Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Bill Ackman confirms nearly 20% stake in Hertz, floats Uber partnership (Investing.com) +++ HERTZ Aktie +6,66%

News zum Sektor Gesundheit aus Belgien

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1561 Aktien zum Sektor Gesundheit bekannt.
 
15.04.25 - 17:30
United Community Banks (UCB) Earnings Expected to Grow: Should You Buy? (Zacks)
 
United Community Banks (UCB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
15.04.25 - 16:00
Galapagos′ CFO announces departure (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
15.04.25 - 07:33
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 (GlobeNewswire EN)
 
Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced the departure of its CFO and COO, Thad Huston, effective as of August 1, 2025. Mr. Huston has decided to leave the company and return to the U.S. for personal and professional reasons. Mr. Huston joined Galapagos NV in 2023 from Kite Pharma, Inc., to support Galapagos' transformation into a cell therapy company. The company expects to announce Mr. Huston's successor in the coming months.Paul Stoffels1, MD, CEO and Chair of the Board of Directors of Galapagos, said “Over the past two years, Thad has worked on the transformation of Galapagos into a focused cell therapy business leveraging our unique decentralized cell therapy platform to deliver fresh, stem-like early memory CAR-T therapy with a vein-to-vein time of seven days. Thad wil...
15.04.25 - 00:21
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
 
NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......
11.04.25 - 20:06
OXURION : Publication Annual Report - Annual Shareholders′ Meeting (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
11.04.25 - 08:03
Fagron publishes agenda for 2025 annual shareholders meeting (GlobeNewswire EN)
 
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET...
10.04.25 - 13:51
RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights (PR Newswire)
 
Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Global licensing deal (excluding North America) with Hyloris Pharmaceuticals with RHB-102 for up to $60 million in potential......
10.04.25 - 07:03
Fagron to present its upgraded growth strategy and mid-term financial targets at its Capital Markets Day 2025 (GlobeNewswire EN)
 
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7AM CET...
08.04.25 - 16:09
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH (PR Newswire)
 
NEW YORK, April 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......
08.04.25 - 11:48
Nyxoah erwartet FDA-Freigabe für Genio noch im Frühjahr (4investors)
 
Um den gesamten Artikel unter 4investors.de zu lesen, klicken Sie bitte auf die Überschrift...
08.04.25 - 07:03
Nyxoah Provides Update on FDA Approvable Letter for Genio System (GlobeNewswire EN)
 
Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter...
08.04.25 - 07:03
Corporate News: Nyxoah SA. (EQS)
 
Nyxoah Provides Update on FDA Approvable Letter for Genio System...
07.04.25 - 15:36
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, April 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ: NYXH) for violations of the securities laws. The......
07.04.25 - 07:15
Azelis Nominates Lily Wang to Board of Directors (Business Wire)
 
ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis (Brussels:AZE), the reference innovation service provider in the speciality chemicals and food ingredients industry, announces the nomination of Lily Wang as a non-executive and independent director. With over 20 years of significant international business experience in the chemicals industry, Ms. Wang's extensive expertise will further contribute to strengthening Azelis's strategy. As from 8 May, Ms. Wang would be succeeding Ipek Özsüer, who has provided significant contributions to our digitalisation efforts since joining the Board of Directors in 2021. Ms. Wang's appointment is subject to approval by the shareholders of Azelis Group NV at the Annual General Meeting. Beginning her professional career in China with Bayer Group in 2002, Ms. Wang has held numerous executive roles across Europe, Asia and America at both Bayer and, subsequently, Covestro, including Senior Vice President, Global Electronic, Electrical and Appliance and Global Dis...
04.04.25 - 15:24
Investor Woche: Börsencrash durch Trumps Zollhammer, Magnificent 7, Berkshire Hathaway, Anheuser Busch, EON, Allianz, Pfizer (Verumo)
 
Trumps Zollhammer lässt die Aktienmärkte weltweit abstürzen. Besonders betroffen: Die Magnificent 7. Warren Buffetts hohe Cash-Reserven könnten Berkshire Hathaway zugutekommen. Unternehmen mit geringer Zollabhängigkeit zeigen sich vergleichsweise stabil....
04.04.25 - 15:12
Galapagos Named Top Travel Destination for North Americans in Ultimate Showdown (PR Newswire)
 
Exodus Adventure Travels Announces Results of Major March Bracket Competition NEW YORK, April 4, 2025 /PRNewswire/ -- As millions of North Americans engage in their championship brackets, Exodus Adventure Travels, the leading international small group guided tour company, today announced......
04.04.25 - 14:01
OXURION : Postponement Annual Shareholders Meeting (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
04.04.25 - 07:03
IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day (GlobeNewswire EN)
 
Louvain-la-Neuve, Belgium, 04 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast....
03.04.25 - 13:01
UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025 (PR Newswire)
 
24 scientific abstracts reflect UCB's ongoing commitment to improving outcomes for people living with neurological conditions, including rare epilepsies Dravet syndrome and Lennox-Gastaut syndrome, as well as generalized myasthenia gravis and thymidine kinase 2 deficiency. Research......
02.04.25 - 19:39
Celyad Oncology SA GAAP EPS of -€0.14, revenue of €0.2M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer nichts bietet, bietet billige Preise. - Franziska Friedl
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!